Stocktoria
Gerresheimer AG GXI.DE
DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website
Gerresheimer AG financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €2.3B | €2.0B | €2.0B | €1.8B |
| Gross profit | €425.3M | €568.2M | €597.3M | €546.8M |
| R&D expense | €81.0M | €23.8M | €16.1M | €21.6M |
| SG&A expense | €381.1M | €341.7M | €326.0M | €304.6M |
| Operating income | -€70.8M | €192.1M | €229.5M | €193.7M |
| Interest expense | €97.8M | €60.6M | €50.4M | €28.0M |
| Income tax | -€11.4M | €26.0M | €47.3M | €38.6M |
| Net income | -€320.3M | €82.3M | €116.1M | €96.1M |
| EPS (diluted) | €-9.27 | €2.38 | €3.48 | €3.06 |
| Operating cash flow | €209.5M | €239.0M | €294.3M | €221.9M |
| Free cash flow | -€98.8M | -€130.6M | -€33.7M | -€19.6M |
| Cash & equivalents | €176.2M | €186.4M | €122.3M | €112.8M |
| Inventory | €446.5M | €356.1M | €327.4M | €304.4M |
| Goodwill | €870.7M | €676.4M | €670.1M | €684.8M |
| Total assets | €4.5B | €3.8B | €3.4B | €3.4B |
| Total debt | €2.2B | €1.3B | €1.0B | €1.2B |
| Total liabilities | €3.4B | €2.3B | €2.0B | €2.1B |
| Shareholders' equity | €1.1B | €1.5B | €1.4B | €1.2B |
Growth · year-over-year · Revenue CAGR 8.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +16.6% | +0.0% | +9.5% | — |
| Net income growth | -489.3% | -29.2% | +20.8% | — |
| EPS growth | -489.5% | -31.6% | +13.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · DE · as of 2025-11-30. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.